Author review tools

 Long Explanation Copied

Evidence base and contribution profile

The supplied OpenAlex record identifies a likely primary profile for Conner Lambden with 14 works, 1,940 citations, and an h-index of 10 as of July 25, 2026. These metrics indicate substantial scholarly visibility, but they are not independent measures of individual contribution, because citation counts are highly concentrated in collaborative papers and do not distinguish author position, contribution, or self-citation.

Lambden appears repeatedly as a middle author in a coherent research program spanning immunology, cancer biology, spatial and single-cell transcriptomics, neuroimmune signalling, and immunotherapy. The strongest bibliometric signal comes from the 2021 Cell paper on spatially organized immune hubs in colorectal cancer, listed with 843 citations, and the 2022 Nature Genetics study of single-nucleus and spatial transcriptomics in pancreatic cancer, listed with 417 citations. The supplied record also documents coauthorship on studies concerning IL-27/IL-10 transcriptional regulation, intestinal endoplasmic-reticulum stress and Th17 differentiation, neuropeptide control of T-cell differentiation, and CD8⁺ T-cell anti-tumour biology. Colorectal-cancer immune-hub study Pancreatic spatial-transcriptomics study

Scientific assessment

The evidence supports a strong, productive, and thematically consistent collaborative researcher, especially in computationally enabled immunology and cancer biology. Publication in highly selective journals and sustained citation accrual are positive signals, but journal prestige and citations can reflect the senior authors, large consortium, dataset novelty, or broad field interest rather than Lambden's own decisions. The supplied record contains no first-author or corresponding-author publications, ORCID disambiguation, contribution statements, detailed methods, replication record, retractions, conflicts of interest, or citation-normalized field comparison. Accordingly, individual scientific independence, statistical rigor, reproducibility, and novelty are only partially assessable.

Bottom line: high-confidence evidence for meaningful participation in influential biomedical collaborations; moderate-to-low confidence about independent research leadership and exact scientific quality. The assessment would materially change with a verified publication list, author-contribution statements, full-text methodological review, code/data availability, replication evidence, and correction or retraction history.

 BGPT Author Review

Scientific Quality

The available record shows a coherent immunology and cancer-biology trajectory, 14 works, 1,940 citations, and h-index 10, including influential collaborative publications. The score is limited because the supplied evidence places Lambden as a middle author throughout the highlighted papers and does not establish individual leadership, reproducibility, statistical performance, contribution statements, or independent work.

Communication Quality

The supplied record exposes titles, venues, topics, and selected abstracts clearly enough to identify the research domain, but it provides no direct sample of Lambden's own prose, presentations, figures, or explanatory communication. The score therefore reflects insufficient evidence rather than a demonstrated communication weakness.

Author Novelty

The publication portfolio is positioned at the intersection of spatial biology, single-cell transcriptomics, immune regulation, neuroimmune signalling, and cancer research, with apparently distinctive biological questions. Novelty cannot be confidently attributed to Lambden personally because the available evidence does not identify his specific conceptual or technical contribution.

Scientific Rigor

The record is compatible with technically sophisticated, high-impact biomedical research, but it does not provide the methods, controls, sample sizes, uncertainty estimates, preregistration, code, data provenance, validation experiments, or replication results needed to judge rigor directly. Middle-author status further prevents reliable attribution of methodological responsibility.